Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the recipient of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 1,369 shares, a growth of 138.9% from the February 12th total of 573 shares. Based on an average daily volume of 11,580 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 11,580 shares, the days-to-cover ratio is currently 0.1 days.

Revolution Medicines Trading Down 8.5%

Shares of RVMDW stock opened at $1.72 on Thursday. Revolution Medicines has a 12 month low of $0.03 and a 12 month high of $3.59. The business’s 50 day moving average is $1.99 and its two-hundred day moving average is $1.01.

About Revolution Medicines

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.